* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Onyx Pharmaceuticals

                   

When Science, Marketing, and Investing Collide (at Motley Fool)

yahoo.com
Oct 9, 2008 26 related
        

As a scientist, I'm all for full disclosure. The baby with the bathwater Pfizer's problem revolves around clinical trials for its epilepsy drug Neurontin. It allegedly delayed the release, or never published the results, of...

add comment
themoneytimes.com: Results IMPACT Volatility at Dendreon themoneytimes.com

Results IMPACT Volatility at Dendreon

themoneytimes.com
Oct 8, 2008 3 related
        

Teaser: Investors didn't seem to know what to make of Dendreon 's (Nasdaq: DNDN) announcement of interim data from its phase 3 trial -- called IMPACT -- for its Provenge prostate-cancer treatment yesterday. The company's stock...

add comment
                   

3 Drugmakers With Multiple Shots on Goal (at Motley Fool)

yahoo.com
Oct 1, 2008 1 related
        

Investing in development-stage drugmakers is risky. So many candidates, so little cash Exelixis is a drug discovery machine. With a goal of adding three new compounds to the pipeline each year, Exelixis has no worries about...

add comment

Onyx Pharmaceuticals (ONXX) NewsBite - ONXX Could Be On the Move

pharmiweb.co.uk
Aug 28, 2008
        

Posted on Wednesday, August 27, 2008 3:18 PM Onyx Pharmaceuticals (ONXX) could be on the move today and is now at $40.80, down $0.44 (-1.07%) on volume of 494,982 shares traded. Over the last 52 weeks the stock has ranged...

add comment

Onyx and Bayer enrolling patients in Nexavar trial

ibtimes.com
Aug 21, 2008 10 related
        

NEW YORK - Onyx Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. said Thursday they are enrolling patients in a late stage trial of their drug Nexavar as a post-surgery treatment for liver cancer. Nexavar has...

add comment
                   

A Gardasil Gotcha (at Motley Fool)

yahoo.com
Aug 21, 2008 2 related
        

Getting a drug through the FDA often isn't enough for drug companies. To make money, they've also got to persuade someone -- usually health insurers like UnitedHealth Group (NYSE: UNH) or Aetna (NYSE: AET) -- to pay for the...

add comment

Palo Alto fund uses patents to gain healthcare investing edge

menafn.com
Aug 21, 2008 4 related
        

Patents give healthcare fund manager an edge Palo Alto Investors likes Onyx, Amicus and Cyberonics By Alistair Barr, MarketWatch SAN FRANCISCO (Menafn - Palo Alto Investors is a $1.7 billion fund manager that looks for...

add comment
                   

InPlay: Skechers USA responds to Heelys' announcement, saying, "we continue to believe our offer...

yahoo.com
Aug 21, 2008 14 related
        

8:57AM On The Wires : O2Micro (OIIM) was issued 8 claims under United States patent number 7,385,795 for its Cordless Power Tool invention... Raser Technologies (RZ) announces that it has completed setting the first 20...

add comment
                   

InPlay: Evercore Partners confirms it will receive $120 mln investment from Mizuho Corporate Bank...

yahoo.com
Aug 21, 2008 12 related
        

8:57AM On The Wires : O2Micro (OIIM) was issued 8 claims under United States patent number 7,385,795 for its Cordless Power Tool invention... Raser Technologies (RZ) announces that it has completed setting the first 20...

add comment
                   

Browsing Among Biotechs (Today From Barron's)

smartmoney.com
Aug 20, 2008 3 related
        

Browsing Among Biotechs By Lawrence C. Strauss |Published: August 20, 2008 Active Discussions on SmartMoney THE OUTCOME OF Bristol-Myers Squibb's $4.5 billion bid for the portion of ImClone Systems that it doesn't already own...

add comment
1 2 3 4 5 next »